The FDA has granted accelerated approval to Modeyso™ (dordaviprone) as the first treatment for recurrent H3 K27M-mutant ...

The FDA has accepted Bristol Myers Squibb’s Priority Review application for Breyanzi® (lisocabtagene maraleucel) as a ...

The ARANOTE trial showed that adding darolutamide to ADT reduced the risk of progression or death by 46% in metastatic ...

Researchers have identified eIF2A as a key protein that guides melanoma cells during metastasis. Known for its role in aiding ...

This weekend, the Pan-Mass Challenge (PMC) unites more than 6,500 riders and 3,500 volunteers for its 46th ride, with the ...

A multi-institutional study found that 42% of ovarian cancer patients in clinical remission still harbored minimal residual ...

A novel radioimmunotherapy strategy has shown compelling efficacy in eliminating ovarian cancer stem cells in preclinical ...

The popular artificial sweetener sucralose may impair cancer immunotherapy by depleting arginine—an amino acid essential for ...

Gnosis has announced the launch of EdenDx, the first non-invasive, liquid-based cytology test for early endometrial cancer ...

Researchers have enhanced cisplatin’s efficacy in advanced NSCLC by transplanting functional mitochondria from cardiomyocytes ...

A global study demonstrated that CAR-T cell therapy is linked to significantly increased risks of secondary cancers—8.9-fold ...